$TXMD TherapeuticsMD, Inc. Insider Trading
Get free email notifications about insider trading in TherapeuticsMD, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TherapeuticsMD, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in TherapeuticsMD, Inc. for free.
CIK Number: 0000025743
IRS Number: 870233535
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: TXMD
Company Address: 951 YAMATO ROAD, SUITE 220 BOCA RATON 33431
Phone number: 561-961-1900
Former name: CROFF OIL CO, date of change: 1992-07-03
Former name: CROFF ENTERPRISES INC, date of change: 1997-09-15
Former name: AMHN, Inc., date of change: 2009-09-30
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
TherapeuticsMD, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 12 2021 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | CAO and VP Finance | Option Exercise | M | 0.00 | 19,000 | 0 | 38,000 | |
May 12 2021 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | CAO and VP Finance | Sell | S | 1.04 | 4,842 | 5,036 | 14,158 | 19 K to 14.2 K (-25.48 %) |
May 12 2021 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | CAO and VP Finance | Buy | M | 0.00 | 19,000 | 0 | 19,000 | 0 to 19 K |
May 12 2021 | TXMD | TherapeuticsMD, In ... | Walker Marlan D | General Counsel | Option Exercise | M | 0.00 | 50,500 | 0 | 101,000 | |
May 12 2021 | TXMD | TherapeuticsMD, In ... | Walker Marlan D | General Counsel | Sell | S | 1.04 | 21,592 | 22,456 | 28,908 | 50.5 K to 28.9 K (-42.76 %) |
May 12 2021 | TXMD | TherapeuticsMD, In ... | Walker Marlan D | General Counsel | Buy | M | 0.00 | 50,500 | 0 | 50,500 | 0 to 50.5 K |
May 12 2021 | TXMD | TherapeuticsMD, In ... | BORKOWSKI EDWARD | EVP, Operations | Option Exercise | M | 0.00 | 103,500 | 0 | 207,000 | |
May 12 2021 | TXMD | TherapeuticsMD, In ... | BORKOWSKI EDWARD | EVP, Operations | Sell | S | 1.04 | 44,252 | 46,022 | 59,248 | 103.5 K to 59.2 K (-42.76 %) |
May 12 2021 | TXMD | TherapeuticsMD, In ... | BORKOWSKI EDWARD | EVP, Operations | Buy | M | 0.00 | 103,500 | 0 | 103,500 | 0 to 103.5 K |
May 12 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | Secretary/CEO of su ... | Option Exercise | M | 0.00 | 103,500 | 0 | 207,000 | |
May 12 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | Secretary/CEO of su ... | Sell | S | 1.04 | 44,252 | 46,022 | 1,752,703 | 1.8 M to 1.8 M (-2.46 %) |
May 12 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | Secretary/CEO of su ... | Buy | M | 0.00 | 103,500 | 0 | 1,796,955 | 1.7 M to 1.8 M (+6.11 %) |
May 12 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.00 | 158,334 | 0 | 316,666 | |
May 12 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 1.04 | 67,697 | 70,405 | 17,991,637 | 18.1 M to 18 M (-0.37 %) |
May 12 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.00 | 158,334 | 0 | 18,059,334 | 17.9 M to 18.1 M (+0.88 %) |